By Counterforce Health Team in Tecentriq (atezolizumab) —

Work With Your Doctor to Get Tecentriq (atezolizumab) Covered by Aetna (CVS Health) in New York: Forms, Appeals, and Clinical Evidence

Quick Answer: Getting Tecentriq Approved by Aetna in New York

Aetna (CVS Health) requires prior authorization for Tecentriq (atezolizumab) with strict biomarker requirements. Your doctor must submit clinical documentation showing FDA-approved indication, PD-L1 testing results (when required), and negative EGFR/ALK mutations for lung cancer. If denied, you have 180 days for internal appeals, then 4 months for external review through New York State Department of Financial Services. Start today: Ask your oncologist to check Aetna's formulary status and begin gathering biomarker test results and treatment history.

Table of Contents

  1. Set Your Goal: Understanding Aetna's Requirements
  2. Prepare for Your Doctor Visit
  3. Build Your Evidence Kit
  4. Medical Necessity Letter Structure
  5. Support Your Doctor in Peer-to-Peer Reviews
  6. Document Everything After Your Visit
  7. Practice Respectful Persistence
  8. Appeals Process in New York
  9. Common Denial Reasons & Solutions
  10. Financial Assistance Options

Set Your Goal: Understanding Aetna's Requirements

Getting Tecentriq (atezolizumab) approved requires meeting Aetna's specific clinical criteria. Here's what your partnership with your doctor needs to accomplish:

Coverage Requirements at a Glance

Requirement What It Means Where to Find It
Prior Authorization Mandatory for all cancer uses Aetna Precertification List
FDA-Approved Indication Must match labeled cancer type/stage FDA Label
PD-L1 Testing (NSCLC) ≥1% for adjuvant; ≥50% for first-line Aetna Policy 0909
Biomarker Status Negative EGFR/ALK (unless progressed) Aetna Policy 0909
Formulary Tier Specialty (Tier 4) - high cost-sharing Aetna Formulary

Your doctor will need to demonstrate that Tecentriq is medically necessary for your specific cancer type and that you meet all biomarker requirements.

Prepare for Your Doctor Visit

Come to your appointment with organized information that helps your doctor build the strongest possible case:

Your Symptom and Treatment Timeline

Document these details in chronological order:

  • Initial diagnosis date and staging
  • All previous treatments (chemotherapy, radiation, surgery) with dates
  • Treatment responses (scans showing progression, stable disease, or improvement)
  • Side effects or toxicities that led to treatment changes
  • Current symptoms affecting your daily function

Functional Impact Notes

Be specific about how your cancer affects your life:

  • Energy levels and ability to work
  • Physical limitations (walking, climbing stairs)
  • Changes in appetite or weight
  • Sleep disruption or pain levels

This information helps your doctor explain why delays in treatment could harm your health—crucial for expedited appeals if needed.

Build Your Evidence Kit

Work with your care team to gather these essential documents:

Required Lab and Imaging Results

  • Pathology report with cancer type and staging
  • PD-L1 testing results (for lung cancer patients)
  • Biomarker testing showing EGFR, ALK, and other mutation status
  • Recent scans documenting disease progression or response
  • Complete blood counts and organ function tests

Published Guidelines and References

Your doctor will reference these in the medical necessity letter:

  • FDA-approved indications for your cancer type
  • NCCN Guidelines recommendations
  • Clinical trial data supporting Tecentriq use

Medication History Summary

Create a one-page summary including:

  • All cancer treatments tried with dates
  • Reasons each treatment was stopped (progression, toxicity, intolerance)
  • Current medications and allergies
  • Previous insurance approvals or denials

Medical Necessity Letter Structure

Your doctor's letter to Aetna must include specific elements. Here's what should be covered:

Essential Components Checklist

Patient Information:

  • Full name, date of birth, Aetna member ID
  • Primary cancer diagnosis with ICD-10 code
  • Tumor histology, stage, and biomarker results

Clinical Rationale:

  • Specific FDA indication being requested
  • Why Tecentriq is appropriate for your case
  • Previous treatments and their outcomes
  • Risks of treatment delay

Supporting Evidence:

  • PD-L1 expression levels (when required)
  • Confirmation of negative actionable mutations
  • NCCN guideline version and recommendation
  • Proposed dosing schedule (1200 mg every 3 weeks or 1680 mg every 4 weeks)

Sample Clinical Rationale Language

"Patient has metastatic non-small cell lung cancer with PD-L1 expression of 60% by FDA-approved SP142 assay. EGFR and ALK testing are negative. Following progression on first-line platinum-based chemotherapy, NCCN Guidelines v.2024 recommend atezolizumab 1200 mg IV every 3 weeks as standard second-line therapy. This treatment is medically necessary to provide guideline-concordant care."

Counterforce Health helps clinicians craft evidence-based appeals by analyzing denial letters and payer policies to identify exactly what documentation is needed for approval. Their platform streamlines the process of turning insurance denials into targeted, successful appeals.

Support Your Doctor in Peer-to-Peer Reviews

If Aetna requests a peer-to-peer review, your doctor will discuss your case directly with an Aetna medical reviewer. Here's how you can help:

Offer Scheduling Flexibility

  • Provide your doctor with your availability for urgent decisions
  • Be prepared to come in for additional tests if requested
  • Keep your phone available in case your doctor needs to confirm details

Prepare a Concise Case Summary

Work with your doctor to create a one-page summary:

  • Your cancer timeline in bullet points
  • Key test results and dates
  • Why alternatives won't work for your case
  • Urgency factors (symptoms, disease progression)

Key Points for Your Doctor to Emphasize

  • FDA approval for your specific indication
  • NCCN guideline support (include version number)
  • Previous treatment failures and reasons
  • Biomarker results supporting Tecentriq use
  • Medical urgency if treatment delays risk your health

Document Everything After Your Visit

Keep detailed records to support potential appeals:

What to Save

  • Prior authorization submission (copy of all forms and attachments)
  • Aetna's response (approval or denial letter)
  • All communication between your doctor's office and Aetna
  • Your insurance card and policy information
  • Receipts for any out-of-pocket costs

How to Use Your Patient Portal

  • Message your doctor through the portal for documentation
  • Request copies of all test results and clinic notes
  • Track submission dates for prior authorization requests
  • Monitor approval status if Aetna provides online tracking

Practice Respectful Persistence

Insurance approvals often require follow-up. Here's how to stay engaged without overwhelming your care team:

Appropriate Contact Cadence

  • Week 1: Confirm prior authorization was submitted
  • Week 2: Check if Aetna requested additional information
  • Week 3: Ask about approval status and next steps
  • After denial: Discuss appeal options within 24-48 hours

How to Escalate Politely

If you're not getting responses:

  1. Ask to speak with a nurse navigator or patient advocate
  2. Request a supervisor if staff seem unresponsive
  3. Contact Aetna directly using member services number on your card
  4. Involve your primary care doctor if they can help coordinate

Remember that your care team wants to help you get approved—they're dealing with multiple insurance companies and complex requirements daily.

Appeals Process in New York

New York provides strong protections for patients denied coverage. Here's your roadmap:

Internal Appeals with Aetna

Timeline: File within 180 days of denial Process:

  1. Call Aetna member services at the number on your card
  2. Request internal appeal forms
  3. Submit with additional clinical documentation
  4. Standard decisions within 30-45 days; expedited within 72 hours for urgent cases

External Review Through New York State

If Aetna upholds the denial, you can appeal to an independent reviewer:

Timeline: File within 4 months of final internal denial Process:

  1. Complete New York External Appeal Application
  2. Submit via DFS Portal or mail
  3. Include $25 fee (waived for Medicaid or financial hardship)
  4. Decision within 72 hours (24 hours for urgent drug appeals)

Key Advantage: External review decisions are binding on Aetna—if you win, they must cover Tecentriq.

Free Help Available

  • Community Health Advocates: 888-614-5400 (free assistance with appeals)
  • New York State Department of Financial Services: Consumer assistance for insurance disputes

Common Denial Reasons & Solutions

Denial Reason How to Overturn
"Not FDA-approved for indication" Submit FDA label showing approved use for your cancer type
"PD-L1 testing not provided" Order FDA-approved assay (SP142) and submit results
"Must try preferred alternatives first" Document contraindications or failures with other PD-1/PD-L1 inhibitors
"Experimental/investigational" Cite FDA approval date and NCCN guideline support
"Non-formulary" Request formulary exception with clinical justification
From Our Advocates: We've seen many Tecentriq denials overturned when providers included specific PD-L1 assay results and clearly documented why patients couldn't use preferred alternatives like pembrolizumab. The key is addressing the exact reason for denial with targeted clinical evidence.

Financial Assistance Options

Even with insurance approval, Tecentriq can be expensive. Explore these options:

Manufacturer Support

  • Genentech Copay Program: May reduce out-of-pocket costs for eligible commercial patients
  • Patient Foundation: Financial assistance for uninsured or underinsured patients
  • Visit Genentech Access Solutions for applications

New York State Programs

  • Medicaid: Expanded coverage for low-income adults
  • Essential Plan: Low-cost coverage for those above Medicaid limits
  • COBRA subsidies: May be available for job loss situations

Hospital Financial Assistance

Many New York hospitals offer charity care or payment plans. Ask your cancer center's financial counselor about available programs.

FAQ

How long does Aetna prior authorization take in New York? Standard decisions are typically made within 72 hours for specialty drugs. Expedited reviews (for urgent cases) are completed within 24 hours.

What if Tecentriq isn't on Aetna's formulary? You can request a formulary exception by having your doctor submit clinical justification for why Tecentriq is medically necessary and preferred alternatives aren't suitable.

Can I get an expedited appeal in New York? Yes. If your health is at serious risk, both Aetna internal appeals and New York external appeals can be expedited. Decisions are made within 24-72 hours for urgent cases.

Does step therapy apply if I tried other immunotherapies outside New York? Yes, previous treatment history follows you regardless of where you received care. Make sure your new doctor has complete records of all prior therapies.

What happens if I can't afford the copay even with approval? Genentech offers copay assistance programs for eligible commercial patients. Additionally, many cancer centers have financial counselors who can help identify foundation grants and other assistance programs.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Insurance policies and state regulations change frequently. Always verify current requirements with Aetna and consult your healthcare provider for medical decisions. For personalized help with insurance appeals, Counterforce Health provides evidence-based appeal services that turn denials into approvals by analyzing payer policies and crafting targeted clinical arguments.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.